Finding patterns in lung cancer protein sequences for drug repurposing
Open Access
- 7 May 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0322546
Abstract
Proteins are fundamental biomolecules composed of one or more chains of amino acids. They are essential for all living organisms, contributing to various biological functions and regulatory processes. Alterations in protein structures and functions are closely linked to diseases, emphasizing the need for in-depth study. A thorough understanding of these associations is crucial for developing targeted and more effective therapeutic strategies.Computational analyses of biomedical data facilitate the identification of specific patterns in proteins associated with diseases, providing novel insights into their biological roles. This study introduces a computational approach designed to detect relevant sequence patterns within proteins. These patterns, characterized by specific amino acid arrangements, can be critical for protein functionality. The proposed methodology was applied to proteins targeted by drugs used in lung cancer treatment, a disease that remains the leading cause of cancer-related mortality worldwide. Given that non-small cell lung cancer represents 85–90% of all lung cancer cases, it was selected as the primary focus of this study.Significant sequence patterns were identified, establishing connections between drug-target proteins and proteins associated with lung cancer. Based on these findings, a novel computational framework was developed to extend this pattern-based analysis to proteins linked to other diseases. By employing this approach, relationships between lung cancer drug-target proteins and proteins associated with four additional cancer types were uncovered. These associations, characterized by shared amino acid sequence features, suggest potential opportunities for drug repurposing. Furthermore, validation through an extensive literature review confirmed biological links between lung cancer drug-target proteins and proteins related to other malignancies, reinforcing the potential of this methodology for identifying new therapeutic applications.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (FPI PRE2019-090912)
- Ministerio de Ciencia e Innovación (PID2021-122659OB-I00)
- Ministerio de Ciencia e Innovación (PDC2022-133173-I00)
This publication has 71 references indexed in Scilit:
- De novo protein design—From new structures to programmable functionsCell, 2024
- Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cellsChemico-Biological Interactions, 2022
- Drug Repurposing: A Network-based Approach to Amyotrophic Lateral SclerosisNeurotherapeutics, 2021
- Development of new disulfiram analogues as ALDH1a1-selective inhibitorsBioorganic & Medicinal Chemistry Letters, 2021
- UCSF ChimeraX: Meeting modern challenges in visualization and analysisProtein Science, 2017
- ALDH1A3, a metabolic target for cancer diagnosis and therapyInternational Journal of Cancer, 2016
- Vismodegib: revisiónActas Dermo-Sifiliograficas, 2014
- Methods of Protein Structure Comparison2011
- Scoring residue conservationProteins: Structure, Function, and Bioinformatics, 2002
- Identification of common molecular subsequencesJournal of Molecular Biology, 1981